DAVION HEALTHCARE PLC (DAVI) Form 424B3 — Oct 20, 2026

Davion Healthcare Plc filed a prospectus supplement announcing a leadership overhaul effective when its shares begin trading on Nasdaq on October 22, 2026 under the symbol DAVI. Glenn Williams will become CEO and Jeremy North COO, while current CEO Jack Kaye transitions to Executive Chairman and Sir Eric Peacock steps down as Chairman to remain an independent director. The incoming executives bring deep healthcare and M&A backgrounds: Williams has participated in over $1 billion of M&A activity and helped prepare Care Finders Total Care for a $350 million-plus sale, while North led the turnaround and sale of CloudMade Group to Stellantis.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.